Financhill
Sell
37

CLRB Quote, Financials, Valuation and Earnings

Last price:
$0.24
Seasonality move :
-2.17%
Day range:
$0.23 - $0.25
52-week range:
$0.22 - $4.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
657.46x
P/B ratio:
6.26x
Volume:
2.2M
Avg. volume:
3M
1-year change:
-90.86%
Market cap:
$9.7M
Revenue:
--
EPS (TTM):
-$1.90

Earnings Data

Next earnings date for CLRB
Mar 27
2025
Most recent earnings per share
-$0.40
Missed by $0.03
(Nov 18/2024)
Consensus Estimate
-$0.37
(Nov 18/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLRB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/27/2025 Q4 -- -- -- -$0.35 --
11/18/2024 Q3 -- -- -$0.40 -$0.37 -$0.03
08/13/2024 Q2 -- -- -$0.18 -$0.27 $0.09
05/14/2024 Q1 -- -- -$0.91 -$0.56 -$0.35
03/27/2024 Q4 -- -- -$0.41 -$0.53 $0.12
11/02/2023 Q3 -- -- -$1.21 -$0.45 -$0.77
08/04/2023 Q2 -- -- -$0.73 -$0.67 -$0.07
05/10/2023 Q1 -- -- -$0.76 -$0.87 $0.11
03/21/2023 Q4 -- -- -$0.55 -$1.08 $0.53
11/08/2022 Q3 -- -- -$1.28 -$1.26 -$0.02
08/05/2022 Q2 -- -- -$1.22 -$1.04 -$0.19
05/10/2022 Q1 -- -- -$1.00 -- --
03/02/2022 Q4 -- -- -$0.96 -- --
11/08/2021 Q3 -- -- -$0.97 -- --
08/09/2021 Q2 -- -- -$1.14 -- --
05/10/2021 Q1 -- -- -$1.30 -- --
03/02/2021 Q4 -- -- -$0.70 -- --
11/09/2020 Q3 -- -- -$1.50 -- --
08/10/2020 Q2 -- -- -$2.60 -- --
03/31/2020 Q1 -- -- -$4.20 -- --
12/31/2019 Q4 -- -- -$3.30 -- --
09/30/2019 Q3 -- -- -$4.20 -- --
06/30/2019 Q2 -- -- -$4.60 -- --
03/31/2019 Q1 -- -- -$7.60 -- --
12/31/2018 Q4 -- -- -$8.09 -- --
09/30/2018 Q3 -- -- -$16.50 -- --
06/30/2018 Q2 -- -- -$16.90 -- --
03/31/2018 Q1 -- -- -$20.70 -- --
12/31/2017 Q4 -- -- -$34.00 -- --
09/30/2017 Q3 -- -- -$25.80 -- --
06/30/2017 Q2 -- -- -$23.20 -- --
03/31/2017 Q1 -- -- -$24.00 -- --
03/15/2017 Q4 -- -- -$55.60 -- --
11/11/2016 Q3 -- -- -$43.00 -- --
08/15/2016 Q2 -- -- -$49.00 -- --
05/12/2016 Q1 -- -- $91.00 -- --
03/10/2016 Q4 -- -- $150.00 -- --
11/12/2015 Q3 -- -- -$246.00 -- --
08/12/2015 Q2 -- -- -$302.00 -- --
05/21/2015 Q1 -- -- -$304.00 -- --
03/24/2015 Q4 -- -- -$442.59 -- --

Cellectar Biosciences Earnings Questions

  • How Much did Cellectar Biosciences Generate in Revenue Last Quarter?

    Cellectar Biosciences reported -- worth of top line sales in its most recent quarter.

  • Did Cellectar Biosciences Beat Earnings Last Quarter?

    Cellectar Biosciences announced earnings per share of -$0.40 which represents a miss of analyst forecast a -$0.37 per share.

  • Is Cellectar Biosciences Profitable?

    Cellectar Biosciences reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Cellectar Biosciences EPS Next Year?

    Cellectar Biosciences's earnings are forecast to decrease from -$3.50 per share to -$2.83 per share next year representing a decrease of -58%.

  • When is Cellectar Biosciences's Earnings Date?

    Cellectar Biosciences's next earnings date is March 27, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock